APOL1 and kidney disorder: These preliminary findings may contribute to ongoing intervention strategies for improving transplantation outcomes and suggest the clinical importance of targeted therapeutics for managing APOL1-mediated kidney diseases, particularly for patients carrying the high-risk APOL1 variants as well as allografts harboring high-risk APOL1 variants.